We are pleased to announce that IPMN successfully enrolled their first patient on May 21st in our ongoing clinical study.
Thank you to the dedicated clinical team and our collaborators for making this possible. We look forward to continued progress and impact as the study moves ahead.
Stay tuned for more updates!
